Today: 21 July 2026
Diageo share price today: DGE stock nudges up as investors line up for Feb. 25 results
3 February 2026
1 min read

Diageo share price today: DGE stock nudges up as investors line up for Feb. 25 results

London, February 3, 2026, 09:18 GMT — Regular session

  • Diageo shares edged up in early London trading, clawing back a fraction of Monday’s losses.
  • Investors are zeroing in on the upcoming results, spurred by a routine share-capital update and new broker commentary.
  • Investors will be eyeing the Feb. 25 interim reports closely for signs on demand, pricing, and cash flow.

Diageo shares edged up 0.36% to 1,675.5 pence by 0918 GMT, gaining 6 pence from Monday’s close of 1,669.5 pence. The price fluctuated between 1,673 and 1,689 pence.

That modest shift counts, as the next key date looms. Diageo plans to release interim results on Feb. 25, kicking off with a webcast at 0705 UK time featuring Sir Dave Lewis and Nik Jhangiani. A Q&A session follows at 0930.

Investors are looking for clear signals on whether demand is stabilizing in the U.S. and China after Diageo cut its outlook in November, citing softer conditions in both markets. “There is a plan in place… but whether a new CEO has a different strategy, no one will know,” said Richard Scrope, manager of the VT Tyndall Global Select Fund. Reuters

On Monday, the company released its latest “total voting rights” figure, a standard update shareholders use to check if they need to report stake changes under Financial Conduct Authority rules. Issued share capital was 2,432,425,480 ordinary shares as of Jan. 31, with 205,986,795 held in treasury, leaving total voting rights at 2,226,438,685. The London Stock Exchange’s RNS service carried the announcement. Investegate

Broker buzz remains alive. RBC Capital Markets stuck to its “outperform” rating, setting a 2,000 pence price target, MarketBeat noted. MarketBeat

The backdrop is still challenging. In its fiscal first-quarter trading update last November, Diageo reported flat organic net sales, with volume gains offset by negative price and mix effects. Reported net sales declined 2.2% to $4.9 billion, dragged down by disposals. The company pointed to adverse mix in Asia Pacific, noting weaker performance in China’s “Chinese white spirits.” www.diageo.com

Traders are keeping an eye on the interim figures to see if changes in mix and pricing emerge, along with any improvement in cash flow that might relieve debt and funding strains.

The risk is straightforward: if consumers continue trading down or discounts climb, margins could slide again, pushing another guidance reset back into play.

Feb. 25 is the real trigger here — it’s not just about the headline figures. Investors will be watching closely for any clues on demand trends in crucial markets, as well as management’s take on how they plan to juggle investment, dividends, and fixing the balance sheet.

Shan Ahmed Khan is a senior markets reporter at TS2.tech, specializing in stocks, technology and macroeconomic trends. A graduate of the Lahore University of Management Sciences (LUMS), he previously worked in investment research and market analysis. His coverage helps readers understand the key developments influencing global financial markets and emerging industries.

Stock Market Today

  • Cotton Futures Gain as US Crop Progresses; Oil and Dollar Also Advance
    July 20, 2026, 8:30 PM EDT. Cotton futures advanced by 9 to 37 points on Monday, while crude oil climbed 65 cents a barrel and the US dollar index added 0.209. US cotton crop progress showed 73% squared-1% ahead of average-and 32% setting bolls, matching the 5-year norm. Cotton condition ratings improved to 45% good/excellent. Key contract closes: Oct 26 at 77.37 (+30), Dec 26 at 78.92 (+29), Mar 27 at 80.29 (+28).
Danaher stock price jumps 2% to $223 as DHR snaps losing streak in late trade
Previous Story

Danaher stock price jumps 2% to $223 as DHR snaps losing streak in late trade

Abbott (ABT) stock slips on FDA warning letter over FreeStyle Libre testing; dates to watch
Next Story

Abbott (ABT) stock slips on FDA warning letter over FreeStyle Libre testing; dates to watch

Go toTop